Clinical Trials : Dravet Syndrome

No longer available

Study Name: Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Date: 2012-02-09
Interventions: Drug: stiripentol Stiripentol up to 30 mg/kg/day to control seizures

Available

Study Name: Compassionate Use of Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Date: 2013-04-15
Interventions: Drug: Stiripentol Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth

Completed

Study Name: Verapamil as Therapy for Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2012-05-24
Interventions: Drug: Verapamil Verapamil will be prepared as a solution.

Completed

Study Name: Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome
Condition: Dravet Syndrome
Date: 2016-08-23
Interventions: Device: measure of neuronal excitability

Available

Study Name: Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2013-11-07
Interventions: Drug: Stiripentol

Withdrawn

Study Name: Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2014-06-02
Interventions:

Drug: Clobazam Other Name: Onf

Terminated

Study Name: Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2014-07-09
Interventions: Drug: Clobazam Other Name: Onfi®

Completed

Study Name: A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2016-06-13
Interventions:

Drug: ZX008 - 0.8 mg/kg/day ZX

Not yet recruiting

Study Name: Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome
Condition: Dravet Syndrome
Date: 2014-12-12
Interventions:

Drug: Cannabidiol Oral Solution

Enrolling by invitation

Study Name: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome
Condition: Dravet Syndrome
Date: 2016-06-13
Interventions: Drug: ZX008 (Fenfluramine Hydrochloride)

Search for Clinical Trial Results

Dravet Syndrome - 26 Studies Found

Status	Study
No longer available	Study Name: Stiripentol in Dravet Syndrome Condition: Dravet Syndrome Date: 2012-02-09 Interventions: Drug: stiripentol Stiripentol up to 30 mg/kg/day to control seizures
Available	Study Name: Compassionate Use of Stiripentol in Dravet Syndrome Condition: Dravet Syndrome Date: 2013-04-15 Interventions: Drug: Stiripentol Stiripentol 5-50mg/kg/d divided twice or three times a day by mouth
Completed	Study Name: Verapamil as Therapy for Children and Young Adults With Dravet Syndrome Condition: Dravet Syndrome Date: 2012-05-24 Interventions: Drug: Verapamil Verapamil will be prepared as a solution.
Completed	Study Name: Neuronal Excitability of HCN1 Channel Mutations in Dravet Syndrome Condition: Dravet Syndrome Date: 2016-08-23 Interventions: Device: measure of neuronal excitability
Available	Study Name: Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome Condition: Dravet Syndrome Date: 2013-11-07 Interventions: Drug: Stiripentol
Withdrawn	Study Name: Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome Condition: Dravet Syndrome Date: 2014-06-02 Interventions: Drug: Clobazam Other Name: Onf
Terminated	Study Name: Safety and Tolerability of Clobazam as Adjunctive Therapy in Paediatric Patients Aged ≥1 to ≤16 Years With Dravet Syndrome Condition: Dravet Syndrome Date: 2014-07-09 Interventions: Drug: Clobazam Other Name: Onfi®
Completed	Study Name: A Trial of Two Fixed Doses of ZX008 (Fenfluramine HCl) as an Adjunctive Therapy in Children and Young Adults With Dravet Syndrome Condition: Dravet Syndrome Date: 2016-06-13 Interventions: Drug: ZX008 - 0.8 mg/kg/day ZX
Not yet recruiting	Study Name: Cannabidiol Oral Solution as an Adjunctive Therapy for Treatment of Participants With Inadequately Controlled Dravet Syndrome Condition: Dravet Syndrome Date: 2014-12-12 Interventions: Drug: Cannabidiol Oral Solution
Enrolling by invitation	Study Name: An Open-Label Extension Trial to Assess the Long-Term Safety of ZX008 (Fenfluramine Hydrochloride HCl) Oral Solution in Children and Young Adults With Dravet Syndrome Condition: Dravet Syndrome Date: 2016-06-13 Interventions: Drug: ZX008 (Fenfluramine Hydrochloride)